Lung imaging methods: indications, strengths and limitations.

Imaging methods are fundamental tools to detect and diagnose lung diseases, monitor their treatment and detect possible complications. Each modality, starting from classical chest radiographs and computed tomography, as well as the ever more popular and easily available thoracic ultrasound, magnetic resonance imaging and nuclear medicine methods, and new techniques such as photon counting computed tomography, radiomics and application of artificial intelligence, has its strong and weak points, which we should be familiar with to properly choose between the methods and interpret their results. In this review, we present the indications, strengths and main limitations of methods for chest imaging.

[Rare variation of hepatic blood supply with accessory right and left hepatic artery].

In recent decades, multiple studies have examined the various manifestations of the hepatic blood supply using anatomical preparation and imaging procedures (angiography, CT). Based on these observations, several classifications have emerged to determine blood supply types and their incidence rates. Our aim is to present a rare variation of the arterial blood supply of the liver through an anatomical preparation.

Human Cadaveric Artificial Lung Tumor-Mimic Training Model.

An important phase in surgical training is gaining experience in real human anatomical situations. When a cadaver is available it may complement the various artificial practice models. However, it is often necessary to supplement the characteristics of the cadavers with a simulation of a tumor.

Osteoarcheological and biomolecular evidence of leprosy from an 11-13 century CE Muslim cemetery in Europe (Orosháza, Southeast Hungary).

Orosháza site no. 10 (Southeast Hungary) contains the partially excavated archaeological remains of an 11-13 century CE Muslim merchant village and its cemetery located in close proximity to Christian villages of the same era. The skeleton of a young woman (grave no.

Thallium Labeled Citrate-Coated Prussian Blue Nanoparticles as Potential Imaging Agent.

Background: The aim of this study was to develop and characterize a nanoparticle-based image-contrast platform which is biocompatible, chemically stable, and accessible for radiolabeling with Tl. We explored whether this nanoparticle enhanced the T1 signal which might make it an MRI contrast agent as well.

Methods: The physical properties of citrate-coated Prussian blue nanoparticles (PBNPs) (iron(II);iron(III);octadecacyanide) doped with Tl isotope were characterized with atomic force microscopy, dynamic light scattering, and zeta potential measurement.